Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Personalized Reminiscence Sessions Delivered by a Digital Conversational Agent to Patients With Neurocognitive Disorders

NCT07237009 is registered in ClinicalTrials.gov with KompanionCare SAS as lead sponsor.

NCT NCT07237009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Personalized Reminiscence Sessions Delivered by a Digital Conversational Agent to Patients With Neurocognitive Disorders
Lead sponsor
KompanionCare SAS
Phase
Observational
Overall status
Recruiting
Start date
October 14, 2025
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

apathy, apathy in dementia, cognitive impairment, mild, depression mild, neurocognitive disorders, mild